Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States)

Cancer Causes and Control

Volumn 14, Issue 4, 2003, Pages 319-326

  Sedjo, Rebecca L ^a   Papenfuss, Mary R ^a   Craft, Neal E ^b   Giuliano, Anna R ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b Craft Technologies Inc   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Carotenoids; Human papillomavirus; Micronutrients

Indexed keywords

ALPHA CAROTENE; ALPHA CRYPTOXANTHIN; ALPHA TOCOPHEROL; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; CYANOCOBALAMIN; DELTA TOCOPHEROL; FOLIC ACID; GAMMA TOCOPHEROL; LYCOPENE; RETINOL; TRACE ELEMENT; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER CONTROL; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HAZARD ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUTRIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CAROTENOIDS; FEMALE; HUMANS; MICRONUTRIENTS; NUTRITION ASSESSMENT; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TOCOPHEROLS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VITAMIN A; VITAMIN B 12;

EID: 0038377618     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023981505268     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841.
2. Franco EL (1996) Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am 23: 597-623.
3. Bosch FX, Manos MM, Munoz N, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87: 796-802.
4. Walboomers JM, Jacobs MV, Manos MM, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
5. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G (1993) Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 82: 578-585.
6. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM (1996) Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 88: 261-268.
7. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423-428.
8. Schlecht NF, Kulaga S, Robitaille J, et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. J Am Med Assoc 286: 3106-3114.
9. Schiffman MH, Brinton LA (1995) The epidemiology of cervical carcinogenesis. Cancer 76: 1888-1901.
10. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K (1997) Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 6: 917-923.
11. Sedjo RL, Inserra P, Abrahamsen M, et al. (2002) Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11: 353-359.
12. Sedjo RL, Roe DJ, Abrahamsen M, et al. (2002) Vitamin A, carotenoids and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 11: 876-884.
13. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL (1998) Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer 30: 46-52.
14. Vernon SD, Unger ER, Williams D (2000) Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38: 651-655.
15. Giuliano AR, Harris RB, Sedjo RL, et al. (2002) Incidence, prevalence, and clearance of type-specific HPV infections: the young women's health study. J Infect Dis 186: 462-469.
16. Gravitt PE, Peyton CL, Alessi TQ, et al. (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361.
17. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM (1998) Genotyping of 27 human papillomavirus types by using II consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36: 3020-3027.
18. Craft NE (1996) High resolution HPLC method for the simultaneous analysis of carotenoids, retinoids, and tocopherols. FASAB J A527 (Abstr #3039).
19. The Food and Nutrition Board (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington DC: National Academy Press, pp. 444-445, 448-457.
20. The Food and Nutrition Board (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington D.C.: National Academy Press, pp. 512-513, 516-517.
21. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW (1993) Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 2: 335-339.
22. Potischman N, Herrero R, Brinton LA, et al. (1991) A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators. Am J Epidemiol 134: 1347-1355.
23. Goodman MT, Kiviat N, McDuffie K, et al. (1998) The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 7: 537-544.
24. Kanetsky PA, Gammon MD, Mandelblatt J, et al. (1998) Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, Black women. Nutr Cancer 31: 31-40.
25. Arab L, Steck-Scott S, Bowen P (2002) Participation of lycopene and beta-carotene in carcinogenesis: defenders, aggressors, or passive bystanders? Epidemiol Rev 23: 211-230.
26. Clinton SK (1998) Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56: 35-51.
27. Di Mascio P, Murphy ME, Sies H (1991) Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53: 194S-200S.
28. Palmer HJ, Paulson KE (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 55: 353-361.
29. Rosl F, Schwarz E (1997) Regulation of E6 and E7 oncogenic transcription. In: Tommasino M, ed. Papillomaviruses in Human Cancer: Role of E6 and E7 Oncoproteins, Austin, Texas: Landes Bioscience and Chapmena & Hall, pp. 25-70.
30. Rosl F, Das BC, Lengert M, Geletneky K, zur Hausen H (1997) Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol 71: 362-370.
31. Moscicki AB, Shiboski S, Broering J, et al. (1998) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132: 277-284.
32. Cooney RV, Franke AA, Hankin JH, et al. (1995) Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev 4: 207-215.
33. Peng YM, Peng YS, Childers JM, et al. (1998) Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer Epidemiol Biomarkers Prev 7: 347-350.